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Introduction
Cardiac surgery is associated with 
pulmonary dysfunction, which can lead 
to postoperative complications such as 
prolong intubation, respiratory distress, and 
reintubation. The reasons for pulmonary 
dysfunction after cardiac surgery includes 
general anesthesia, surgery time, mechanical 
ventilation, atelectasis, fluid overload, 
pleural opening, lung parenchymal injury 
due to cardiopulmonary bypass (CPB) and 
microembolization, pain due to incision, 
chest tubes’ presence, and phrenic nerve 
injury. Preservation of pleural integrity is 
associated with better respiratory function 
and reduced length of stay.[1] Use of left 
internal mammary artery in cardiac surgery 
is also associated with more respiratory 
dysfunction than only saphenous vein 
grafts.[2] In addition, preoperative factors 
such as preexisting lung diseases, smoking, 
old age, and poor nutritional state among 
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Introduction: Cardiac surgery is associated with pulmonary dysfunction and complications such 
as prolonged intubation and reintubation. Bilevel positive airway pressure (BiPAP) machine has 
been used in the clinical settings to improve oxygenation, reduce work of breathing, and avoid 
reintubation. The effect of BiPAP on cardiovascular parameters is not well established, and very 
few studies have targeted hemodynamic changes. The aim of the study was to assess the immediate 
effect of BiPAP on respiratory and hemodynamic parameters in post‑cardiac surgery patients. 
Materials and  Methods: This quasi‑experimental study was done on 33 adult cardiac surgery 
patients. Ethical review committee approval was sought and consent was taken. All patients 
who were in respiratory distress with respiratory rate of >30/min and/or PaO2:FiO2 ratio of <200 
were included. Hemodynamic and respiratory parameters were recorded just before and 15 min 
after BiPAP application. Sample size was determined on the basis of BiPAP effect on one of the 
variables, PaO2:FiO2 ratio. Results: A total of 33 patients were included in the study. The average 
age of the patients was 60.97 ± 10.8, of which 23 (69.7%) were males and 10 (30.7%) females. 
BiPAP application leads to statistically significant improvement in ventilator parameters including 
SaO2 29 (87.7%), PaO2 29 (87.8%), PaCO2 21 (63.6%), and PaO2:FiO2 ratio in 27 (81.8%). 
Conclusion: Ventilatory parameters were significantly improved after BiPAP application in this 
study, but hemodynamic parameters showed no statistically significant change. BiPAP application 
was also able to decrease the need for reintubation in post‑cardiac surgery patients.
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others are a predisposition to complications. 
Respiratory dysfunction in cardiac surgical 
patient appears early in the postoperative 
period, but these changes are usually 
transient and respond to interventions.
Bilevel positive airway pressure (BiPAP) 
machine has been used in the clinical 
settings for patients with pulmonary 
edema,[3] high‑risk postoperative patients, 
and acute hypoxemic respiratory failure. 
When compared with endotracheal 
intubation,[4] the BiPAP is more comfortable, 
has a role in avoiding intubations, provides 
better outcome (mortality and nosocomial 
infection), and helps in avoiding 
ventilator‑associated complications such 
as ventilator‑associated pneumonia and 
need for deep sedation. Other advantages 
include improved oxygenation[5,6] and 
decreased work of breathing which, in 
turn, reduces myocardial oxygen demand. 
It recruits atelectatic alveoli and improves 
lung compliance. It may also have a role in 
reducing the risk of nosocomial infection. 
This is an open access journal, and articles are 
distributed under the terms of the Creative Commons 
Attribution‑NonCommercial‑ShareAlike 4.0 License, which allows 
others to remix, tweak, and build upon the work non‑commercially, 
as long as appropriate credit is given and the new creations are 
licensed under the identical terms.
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Studies have shown that intubation and mechanical 
ventilation in respiratory compromised patients is 
associated with higher mortality,[7] and BiPAP may help in 
reducing such complications.[8]
BiPAP supports respiration during inspiration by applying 
inspiratory positive airway pressure (IPAP; which is the 
sum of pressure support and PEEP), and during expiration 
it acts like positive end‑expiratory pressure by application 
of expiratory positive airway pressure (EPAP). It also 
increases PaO2:FiO2 ratio. Low ratio in cardiac surgical 
patients is associated with higher intensive care unit (ICU) 
mortality and pulmonary complications such as atelectasis 
and pulmonary edema.[9] BiPAP application improves 
atelectasis, and BiPAP has been used in post‑cardiac 
surgery patients to avoid intubation. Some patients may 
not tolerate the mask and become restless. BiPAP may 
not work well in extremely agitated, uncooperative, 
and claustrophobic patients. In addition, it may not be 
beneficial in hemodynamically unstable patients and those 
with excessive airway secretion.
The effect of BiPAP on cardiovascular system is not 
very well established, and very few studies have targeted 
hemodynamic changes. These changes are more important 
for post‑cardiac surgery patients who are not only 
recovering from the effect of cardioplegia but also having 
variable volume status. This is probably the only study 
where all important invasive and noninvasive hemodynamic 
parameters are considered along with ventilator parameters.
The aim of the study was to assess the immediate effect 
of BiPAP on respiratory and hemodynamic parameters in 
those post‑cardiac surgery patients who require noninvasive 
ventilation (NIV).
Materials and Methods
This quasi‑experimental study was performed on 
33 adult cardiac surgery patients between the ages of 
35 and 70 years. Ethical review committee approval 
was sought. All patients on respiratory distress were 
initially managed by higher FiO2 by mask, respiratory 
therapy including nebulization, and prop up position. 
Those patients who remained in respiratory distress with 
respiratory rate of >30/min and PaO2:FiO2 ratio <200 
were included in the study. BiPAP was applied as soon 
as the patient met these two criteria. Patient or family 
refusal and elective application of BiPAP were taken as 
exclusion criteria. Emergency surgery and preexisting 
pulmonary dysfunction patients were also excluded. Before 
initiating BiPAP, possible surgical complications such as 
anastomosis leakage, hemorrhage, pneumothorax, and 
cardiac tamponade were excluded. Decision about BiPAP 
application was taken by on‑call resident after consultation 
with covering consultant of cardiac ICU (CICU). BiPAP 
was explained to these patients and consent was taken. For 
those patients who were unable to give written consent 
due to drowsiness or respiratory distress, it was taken from 
close family members (parents, spouse, and children). This 
decision was made after consultation with ethical review 
committee.
Consecutive cardiac surgical patients who fulfilled BiPAP 
application criteria were included in nonrandomized 
fashion. Sufficient communication was established with the 
patients, so that the procedure is well understood. BiPAP 
applied only to those patients who were present in CICU. 
Full face mask was used to cover the mouth and nose and 
then attached with portable BiPAP machine (VPAP III 
STA QuickNav; ResMed, Australia). It delivers a positive 
pressure through a single air circuit with the exhaled air 
exiting through a mask exhaust vent. Initial settings of IPAP 
12 and EPAP of 6 were applied and gradually increased 
accordingly. No attempt was made to wean off during 
the study period. The patient was monitored for mask 
intolerance, gastric distension, and facial skin laceration.
All data were recorded on a proforma, which included 
demographics, reason for application, SaO2 at the time of 
first application, time it started, total duration of application, 
initial settings, range (minimum and maximum), and 
outcome of BiPAP application. These data were collected 
by residents and consultants who were involved in patient 
management.
Sample size was based on the study by Takami and Ina[10] 
and determined on the basis of the effect on one of the 
variables, PaO2:FiO2 ratio. Changes in the hemodynamic, 
BiPAP parameters, SaO2, PaO2, PaCO2, heart rate (HR), 
mean blood pressure (BP), central venous pressure (CVP), 
pulmonary artery (PA) pressure, systemic vascular 
resistance (SVR), and pulmonary vascular resistance (PVR) 
were calculated from relative changes from the baseline. 
A sample size of 33 achieved 90% power to detect a 20% 
and above mean paired difference with estimated standard 
deviation of the difference being 20, with a significance 
level (alpha) of 0.01 using a paired t‑test.
All statistical analysis was performed using Statistical 
Package for the Social Sciences version 19 (SPSS Inc., 
Chicago, IL, USA). Frequency and percentage were 
computed for categorical observation, while mean and 
standard deviation were estimated for numeric variables. 
Pre‑ and post‑BiPaP effects on dependent variables were 
analyzed by paired t‑test. Repeated measure analysis of 
variance test was applied to observe the effect of other 
variables on dependent variables. A P value of less than 
0.05 was considered as statistically significant.
Results
A total of 33 patients were included in the study. 
The average age of the patients was 60.97 ± 10.8, of 
which 23 (69.7%) were males and 10 (30.7%) females 
[Table 1]. The most common reason for BiPAP application 
was atelectasis (51.5%). Diagnosis was left at the discretion 
[Downloaded free from http://www.annals.in on Friday, April 9, 2021, IP: 221.132.113.70]
Hamid, et al.: BiPAP‑related changes in hemodynamic and gas exchange
Annals of Cardiac Anaesthesia | Volume 23 | Issue 1 | January‑March 2020 61
of CICU intensivist on the basis of X‑ray findings’ 
interpretation. Patients with pneumonia and obesity 
frequently required noninvasive ventilatory support. BiPAP 
application lead to statistically significant improvement 
in the following parameters: SaO2 29 (87.7%), 
PaO2 29 (87.8%), PaCO2 9 (27.3%), and PaO2:FiO2 
ratio in 27 (81.8%). Only four patients in our study had 
PaO2:FiO2 ratio greater than 150, and of these only one 
patient did not show improvement in the ratio after BiPAP 
application [Table 2]. Only two patients required escalation 
of support during the study period.
Eight patients had body mass index (BMI) greater than 30. 
All (n = 3) patients with BMI >35 showed improvement in 
SaO2, PaO2, and PaO2:FiO2 ratio after BiPAP application. 
Nine of 17 patients who were in respiratory distress due 
to atelectasis needed BiPAP application for less than 24 h. 
BiPAP was applied preemptively on three patients soon 
after extubation due to low PaO2:FiO2 ratio on ventilator. 
HR reduced from mean 102 to 92 beats/min, while the 
mean BP was increased [Table 3]. Cardiac output which 
was measured after 15 min of BiPAP application also 
reduced from mean 4.45 ± 1.23 to 4.50 ± 1.34 L/min with 
a P value of 0.873.
Thirteen (36.4%) patients required BiPAP support for less 
than 24 h. Only one patient required reintubation in the first 
24 h, and overall 6 (18.2%) patients ultimately required 
reintubation after prolonged BiPAP application [Table 4]. 
Three patients required reapplication of BiPAP within 24 
h after planned removal. Four of five patients who had low 
PaO2 on ventilator required BiPAP for more than 24 h.
Discussion
Application of alternating IPAP and EPAP improves 
gas exchange by recruiting atelectatic alveoli. IPAP 
has an additional advantage of reducing the work of 
breathing. In other studies, respiratory parameters were 
improved in 30 min, while in this study NIV has shown 
improvement within 15 min of application. Zoremba 
et al.[11] in their study noticed that the short‑term use 
of BiPAP can improve pulmonary function for 24 h. 
It decreases the need for sedation, and the patient can 
protect his own airway to protect against aspiration. It 
also decreases nosocomial infection rate when compared 
with reintubation. Diaphragmatic paralysis or dysfunction, 
which is not uncommon in cardiac surgical patients, 
can be an indication for BiPAP application.[12] The other 
advantage includes reduced inotrope requirements and 
respiratory infection.[13]
Early application may have a role in reducing 
mortality.[14] BiPAP also has a role in reducing the need 
for reintubation,[15] particularly in respiratory failure 
patients[3] and in cardiogenic pulmonary edema[6] but 
does not reduce the incidence of myocardial infarction 
and mortality.[16] A meta‑analysis by Bajaj et al.[17] also 
concluded that NIV reduces reintubation (10.8% in NIV 
vs. 17.8% in conventional group) in chronic obstructive 
pulmonary disease and high risk for extubation failure 
patients.




















Results are presented as mean±SD and n (%), Others*: CKD 2, 
obesity 1, AKI 1
Table 2: Reasons, Improvement and total duration of 
BiPAP in cardiac surgery patients (n=33)
Variables n %
Reason for BiPAP Application
Pneumonia 5 15.2%
Sepsis 2 6.1%
Muscle Weakness 4 12.1%
Obesity 4 12.1%
Low PaO2 ventilator 4 12.1%
COPD 1 3%
Pulmonary edema 1 3%
Respiratory distress due to unknown reason 2 6.1%
Respiratory distress due to atelectasis 17 51.5%
Single Reason 7 21.2%
Multiple Reasons 26 78.8%





Clinical Mentation, Drowsiness 7 21.2%
Reduction in respiratory rate after first app BiPAP 12 36.4%
PaO2/FiO2 ratio 27 81.8%
Total Duration of BiPAP
<24 h 12 36.4%
2‑3 days 19 57.6%
3‑5 or above 2 6.1%
Results are presented as n (%)
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It may also reduce intubation rate in acute respiratory 
failure.[18] It reduces the reintubation rate in patients who 
are at high risk for postoperative pulmonary complications 
or have ongoing acute respiratory failure.[19] Prophylactic 
application is ineffective in low‑risk patients, but in 
high‑risk patient even few hours of application[20] reduces 
reintubation rate. Preemptive BiPAP application was 
applied in three patients in our study, and not only it 
improved oxygenation but also it prevented reintubation. 
BiPAP also has a role in reducing intubation rate in acute 
and chronic congestive heart failure (CHF) patients.[21]
BiPAP has a failure rate of 10%–55%, and the main reason 
is pneumonia and older age group.[22] There are various 
definitions of failure. For study purpose, we considered 
reintubation within 4 days of application as BiPAP failure 
and 18% patients needed reintubation in this study. Five 
patients in our study also had pneumonia for which BiPAP 
was applied. Only two patients required reintubation on day 
2 of application, which showed some success, but larger 
studies are needed to conclude in these patients. It may 
be suggested not to use BiPAP in this patient population 
due to higher failure rate, and conventional endotracheal 
intubation must be preferred.[23] Age of the patients seems 
to have no effect on failure rate in this study.
There was a statistically significant improvement in PaO2 
within 15 min of application. It was more effective in 93% 
of patients in whom PaO2 was lower than 60 mmHg (14/15). 
BiPAP improves oxygenation more rapidly than continuous 
positive airway pressure in cardiogenic pulmonary edema 
patients.[3]
It usually increases SaO2 without significant changes 
in PaCO2
[24] in normal patients. But in patients with 
hypercapnia, its role is different. In our study, BiPAP 
application significantly reduces PaCO2 in 21 (63%) 
patients. BiPAP seems to be more efficient in patients 
with hypercapnia as we have seen in our study that most 
of the patients (11 of 14) whose PaCO2 was higher than 
45 mmHg showed reduction in PaCO2 within 15 min of 
BiPAP application. Our results are similar to other studies 
Table 3: Effect of BIPAP application on hemodynamics and ventilator parameters
n Pre BiPAP Post BiPAP P
Gas exchange parameters
SaO2 33 90[88.4, 94] 95[91,97.7] 0.003
PaO2 33 60.2[55.7,70] 69[63.6,98.1] 0.0005
PaCO2 33 44[39.05,51] 40.5[37.1,45.6] 0.005
PaO2/FiO2 ratio 33 107[94,137] 115[103.5,173] 0.001
Base excess 21 0.20[‑0.21, 1.85] 0.30[‑2.3,2.05] 0.259
Hemodynamic parameters
HR 33 102[91,111] 92[89,108.5] 0.18
Systolic BP 33 112[104.5,128.5] 112[105,125.5] 0.443
Diastolic BP 33 63[59,83.5] 69[59,83] 0.702
Mean BP 33 79.5[70,89] 84.5[71,90.7] 0.142
CVP 32 8.5[7,10] 9[7,11] 0.062
PA pressure (Systolic) 20 32[25,37.5] 28[26,38] 0.887
PA pressure (Diastolic) 20 15[13,18] 16[14,18] 0.060
SVR 20 1259[1003,1712] 1264 [999.25,1553] 0.959
CO 14 4.45[2.60,6.25] 4.50[2.51,6.54] 0.873
Results are presented as median [25th, 75th percentile], Wilcoxon Signed Ranks Test
Table 4: Outcome of BiPAP Application (n=33)










Able to maintain SaO2 without BiPAP for 24 h 22 66.7%
BiPAP reapplication within 24 hrs. of removal 3 9.1%
Rate patient’s cooperation after BiPAP application
Fully Cooperative 30 90.90%
Reluctant to Cooperate 2 6.1%
Non Cooperate 1 3%
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carried out earlier, which also showed a significant effect of 
BiPAP only in patients with hypercapnia.[6,25] Mehta et al. 
showed improvement in PaCO2 after BiPAP application, 
but it increases acute myocardial infarction rate (71%).[26] 
Tobias[5] also demonstrated reduction in respiratory rate 
and PaCO2 in postoperative patients. Those patients 
were in impending respiratory failure, and application of 
BiPAP improved oxygenation and CO2 levels and avoided 
reintubation.
We took PaO2:FiO2 ratio of <200 as an inclusion criteria, 
and BiPAP application did improve the ratio significantly. 
The average value of ratio before and after application 
was 107 versus 115. This increase in ratio reached more 
than 200 only in five (15.1%) patients. The reason may be 
that most of our patients (n = 29) had less than 150 ratio 
before BiPAP application. One of the study also used this 
ratio for indication[10] and the ratio increased significantly 
within 3 min. Park et al.[6] also showed improvement in the 
ratio within 10 min of application and required more than 
30 min to reach 200 level but those were pulmonary edema 
patients.
Hemodynamic effects are varied according to the disease 
state and also on the IPAP and EPAP settings and the type 
of mask (nasal vs. face). In normal patients, it may decrease 
CO, while in chronic heart failure patients it may improve 
CO by reducing SVR[27] and preload. Cardiac function 
improved in distended heart but not in normal functioning 
heart. No significant hemodynamic changes were seen 
after BiPAP application during the initial 15 min. It may 
be inferred that it needed more time for hemodynamic 
improvement or it may be more effective in pulmonary 
edema cases as studies have shown a reduction in HR and 
SVR after BiPAP application in pulmonary edema patients. 
BiPAP reduces sympathetic activity,[28] preload, and 
afterload leading to enhanced ventricular function. Mean 
arterial pressure (MAP), CVP, and PA diastolic pressures 
slightly increase probably due to an increase in intrathoracic 
pressure exerted by BiPAP.[29] Insignificant reduction in 
HR and PA systolic pressure was seen in our patients. 
Decrease in HR occurs due to parasympathetic stimulation 
by stretched receptors in lungs. This is in contrast to a 
previous study in post‑cardiac surgery patients by Kilic 
et al. which showed a slight increase in HR at 1 h along 
with a decrease in MAP. These values remain insignificant 
even after 12 h of BiPAP application. Cardiac surgery 
patients are usually in various stages of hemodynamic 
status; some may be hypovolemic or hypervolumic, 
while others may still be recovering from the effect of 
cardioplegia. In addition, hemodynamics are also affected 
by postoperative cardiac index, pain, BiPAP settings, and 
patient’s cooperation. Significant HR reduction was seen in 
two previous studies, but those were with patients CHF and 
the improvement was seen after 30 min.[26,30] This change 
in HR in patients with pulmonary edema was significant 
within 10 min of application in a study by Marcelo et al.
Although CO was increased in our patients, it was 
insignificant. The increase in CO and MAP was probably due 
to reduction in preload and improved cardiac contractility 
after BiPAP. Another study which is comparable to this 
study showed improvement in cardiac index(CI) without 
changes in systemic and PA pressures.[15] Atelectasis and 
overinflation of lung above functional residual capacity 
(FRC) can increase PVR. Takami and Ina showed higher 
systemic vascular resistance index and pulmonary arterial 
resistance index along with low CI in those patients who 
required BiPAP when compared with non‑BiPAP patients. 
It will be interesting to see the changes in ionotropes 
and vasopressors’ requirement in future studies. Another 
limitation relates to heterogeneity of the study subset 
unknown baseline respiratory function (we try to exclude 
these patients), different types of surgical procedures, CPB 
time, and length of postoperative ventilation. Although the 
most common mode for weaning at our institute is SIMV, it 
would have been ideal to standardize the weaning mode in 
all study patients.
Hypoxemia, atelectasis, and respiratory impairment are 
more common in obese cardiac surgery patients, and 
short‑term use of BiPAP was able to improve pulmonary 
functions which lasted for about 24 h after discontinuation. 
It is recommended to commence BiPAP early to achieve 
maximum benefits. This study also showed improvement in 
respiratory parameters in obese patients,[22] particularly in 
patients with BMI greater than 35. There is a suggestion 
to apply BiPAP, soon after extubation in all patients with 
higher BMI. Prophylactic BiPAP also has a role in patients 
with low ejection fraction where it reduces the incidence 
of atelectasis and at the same time increase PaO2.
[31] BiPAP 
can be used as a part of fast‑track extubation. As a weaning 
mode, it reduces extubation time when compared with 
intermittent mandatory ventilation.[32]
Conclusion
Saturation, PaO2, PaCO2, and PaO2:FiO2 ratios were 
significantly improved soon after BiPAP application in this 
study, but no statistically significant changes were seen in 
hemodynamic parameters. BiPAP application was also able 
to reduce the need for reintubation in post‑cardiac surgery 
patients.
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